Related Experiment Videos
Topical treatment of tinea capitis in a neonate
Ronen Mosseri1, Yaron Finkelstein, Ben Zion Garty
1Department of Pediatrics, Schneider Children's Medical Center of Israel, Petah Tiqva, Israel.
Insights
Tinea capitis, a common pediatric fungal infection, is rare in newborns. This case study shows successful treatment of a 16-day-old infant with topical bifonazole 1% for Microsporum canis infection.
Area of Science:
- Dermatology
- Mycology
- Pediatrics
Background:
- Tinea capitis is the most common fungal skin infection in children, typically requiring systemic antifungal treatment due to its invasion of the hair shaft and pilosebaceous unit.
- Neonates are generally more susceptible to infections, yet tinea capitis is notably infrequent in this demographic.
Observation:
- A rare case of tinea capitis was observed in a 16-day-old infant.
- The causative agent was identified as Microsporum canis.
Findings:
- Topical bifonazole 1% proved effective in treating tinea capitis in this neonate.
- This suggests a potential alternative to systemic therapy in specific infant cases.
Implications:
- This case highlights a successful topical treatment approach for tinea capitis in a neonate, a population where the condition is rare.
- It may inform future treatment strategies for superficial fungal infections in very young infants.
Abstract:
Tinea capitis is the most common fungal skin infection in children. Given that this infection invades the hair shaft and the pilosebaceous unit, systemic antifungal therapy is the gold standard of treatment. Despite the neonate's increased susceptibility to infections, tinea capitis is rare in this population. We present the case of a 16-day-old infant with tinea capitis caused by Microsporum canis and effectively treated with topical bifonazole 1%.